celares GmbH establishes collaboration with NOF
NOF CORPORATION and celares GmbH, Germany have established strategic collaboration in the field of PEGylation. The collaboration will enable NOF CORPORATION to strengthen its position in an increasingly competitive market for Activated PEG supply. Collaboration of celares with NOF means a milestone in company development. In joint client projects, celares will use NOF’s high grade pure Activated PEGs. For celares, the collaboration with NOF means a broadening of its market globally.
Other news from the department business & finance

Get the life science industry in your inbox
By submitting this form you agree that LUMITOS AG will send you the newsletter(s) selected above by email. Your data will not be passed on to third parties. Your data will be stored and processed in accordance with our data protection regulations. LUMITOS may contact you by email for the purpose of advertising or market and opinion surveys. You can revoke your consent at any time without giving reasons to LUMITOS AG, Ernst-Augustin-Str. 2, 12489 Berlin, Germany or by e-mail at revoke@lumitos.com with effect for the future. In addition, each email contains a link to unsubscribe from the corresponding newsletter.
More news from our other portals
Last viewed contents
Bone degradation process within metastatic breast cancer identified
New technique multiplies life span in simple organisms

Final report analytica 2012: Decision-makers announce definite intentions to invest - Live Labs generate a great deal of interest
Category:Medical_Council_of_India
Juvenile_idiopathic_arthritis
Woolly_hair_syndrome
Nomad Bioscience: new plant biotechnology company founded to focus on biomaterials and biopharmaceuticals
Usher_syndrome
Jawaharlal_Institute_of_Postgraduate_Medical_Education_&_Research
Phenytoin
Waardenburg_syndrome
